Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB25FR9WP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Skyrizi 360 mg/2.4 mL on-body injectors valued at $11,830. The contract, which represents a non-set-aside, competitively awarded delivery order with firm fixed pricing, is scheduled for completion by October 20, 2025, and will be performed at the company's Conshohocken, Pennsylvania facility. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and military medical networks. As a registered System for Award Management (SAM.gov) vendor, the company maintains an extensive portfolio of federal contract awards across multiple therapeutic domains, including specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices. The DLA Troop Support Medical IDC enables the company to deliver pharmaceutical products and medical supplies to support military healthcare programs globally, positioning AmerisourceBergen as a key vendor within the Defense Logistics Agency's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FR9WP?
SPE2DB25FR9WP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FR9WP worth?
The government has obligated $11,830 on SPE2DB25FR9WP.
Is contract SPE2DB25FR9WP an order under another contract?
Yes. SPE2DB25FR9WP is a delivery order under SPE2DB22D2103, an indefinite delivery contract.
Was contract SPE2DB25FR9WP competed?
The extent of competition for SPE2DB25FR9WP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award